Research and Development

Showing 15 posts of 9594 posts found.

atorvastatin

Copycat Lipitor helps toward £1.3bn NHS savings

July 29, 2014 Research and Development, Sales and Marketing ABPI, Lipitor, NHS, Teva, prescribing PPRS, vba

In 2013 generic usage increased to more than three-quarters of all NHS prescriptions according to new data released by the …
Roche

Roche’s blood cancer drug gains EU approval

July 29, 2014 Research and Development, Sales and Marketing CLL, Cancer, Gilead, Janssen, Roche

The European Commission has approved Roche’s new leukaemia drug Gazyvaro (obinutuzumab) as competition for the blood cancer market heats up. …
renee_mellas_23

Healthcare marketer Renée Mellas re-joins Area 23 as MD

July 29, 2014 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FCS Health

Healthcare and pharma marketing professional Renée Mellas has returned to Area  23, an FCB Health company, as executive vice president …
google_plaque

Google hopes DNA search will yield health results

July 27, 2014 Medical Communications, Research and Development, Sales and Marketing DNA, calico, google, smart lens

Google is to collect samples of human tissue from thousands of people as part of an experiment that could help …
european_flag

Europe warned over cancer research risk

July 27, 2014 Medical Communications, Research and Development, Sales and Marketing ESMO, EU, Macmillan, data

A leading European doctors’ group is warning that new data protection rules could make cancer research ‘impossible’ whilst also adding …
EMA HQ

EMA approvals for rival blood cancer drugs

July 27, 2014 Research and Development, Sales and Marketing CLL, Gilead, Janssen, chronic lymphocytic leukaemia, imbruvica, zydelig

Gilead and Janssen are set to face off in Europe after the CHMP recommended both of their rival blood cancer …
sovaldi_ariad_sofosbuvir_bottle_1

NHS England’s Sovaldi fund: opening the floodgates?

July 26, 2014 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CDG, NICE, Professor David Haslam, hep C, sovaldi

Whilst seemingly more and more barriers are being erected to slow down the adoption of new medicines, there is a …
malaria_vaccine_trial_0

GSK seeks regulatory review of first malaria vaccine

July 26, 2014 Manufacturing and Production, Research and Development, Sales and Marketing China, GSK, malaria, rts, s

GSK has submitted a regulatory application to the European Medicines Agency for its malaria vaccine candidate RTS,S and hopes it …

More action needed on antibiotic resistance

July 25, 2014 Medical Communications, Research and Development, Sales and Marketing AMR, Antibiotics, AstraZeneca, GSK, HIV, MRC, WHO, walsh

Pharma and governments need to put their heads together urgently in order to tackle the threat of antimicrobial resistance (AMR), …
vicky_gregg

New director for Quest Diagnostics

July 25, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing quest diagnostics, vicky gregg

Diagnostic information services firm Quest Diagnostics has confirmed that Vicky Gregg is to serve as a director on its board. Gregg …
Gilead image

FDA approves Gilead’s blood cancer drug

July 24, 2014 Research and Development, Sales and Marketing Cancer, FDA, Gilead, blood, follicular lymphoma and small lymphocytic lymphoma, lymphocytic leukaemia, sovaldi, zydelig

The Food and Drug Administration has approved Gilead Sciences new treatment Zydelig (idelalisib) to treat three types of blood cancer.  …
web_dr_dinesh_bhugra

New president for Mental Health Foundation

July 24, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Dr Dinesh Bhugra, Mental Health Foundation

Dr Dinesh Bhugra who has served as chair of the Mental Health Foundation for three years has been appointed as …
Pradaxa image

BMJ investigation raises new concerns over Pradaxa

July 24, 2014 Medical Communications, Research and Development, Sales and Marketing BMJ, Boehringer, Channel 4, Pradaxa, blood, warfarin

An investigation by The BMJ has raised fresh concerns about Boehringer’s top-selling blood thinner Pradaxa (dabigatran) and the regulatory decisions …
nhs image

Wireless tech cannot substitute nurses

July 23, 2014 Medical Communications, Research and Development, Sales and Marketing Brighton, NHS, RCN, hospital, nursing, wireless tech

The Royal College of Nursing says that whilst a new wireless diagnostic patch is certainly innovative, they are concerned that …
peter_dansky

Agena Bioscience hires Life Technologies president

July 23, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing agena bioscience, peter dansky

Clinical diagnostics firm Agena Bioscience has confirmed that Peter Dansky has joined the company as its chief executive and will …
The Gateway to Local Adoption Series

Latest content